Emtricitabine and tenofovir and Kisqali (200 MG Dose)
Determining the interaction of Emtricitabine and tenofovir and Kisqali (200 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and Tenofovir Disoproxil Fumarate
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine and tenofovir-Kisqali (400 MG Dose)
- Emtricitabine and tenofovir-Kisqali (600 MG Dose)
- Emtricitabine and tenofovir-Kisqali Femara Co-Pack
- Emtricitabine and tenofovir-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Emtricitabine and tenofovir-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Emtricitabine and tenofovir-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Kisqali (200 MG Dose)-Emtricitabine and Tenofovir Alafenamide
- Kisqali (200 MG Dose)-Emtricitabine and Tenofovir Disoproxil Fumarate
- Kisqali (200 MG Dose)-Emtricitabine and Tenofovir Tablets
- Kisqali (200 MG Dose)-Emtricitabine Capsules
- Kisqali (200 MG Dose)-Emtricitabine Solution
- Kisqali (200 MG Dose)-Emtricitabine, lopinavir, ritonavir, and tenofovir